Risankizumab Has Early and Lasting Benefits in Crohn ' s Disease Risankizumab Has Early and Lasting Benefits in Crohn ' s Disease

Risankizumab takes effect within the first few weeks and has enduring effects in Crohn ' s disease, phase 3 trials suggest.Medscape Medical News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news